课题基金 / 基金详情

Treating Inflammatory Bowel Disease by Developing Small Molecule Inhibitors of a Novel Protein Target

Treating Inflammatory Bowel Disease by Developing Small Molecule Inhibitors of a Novel Protein Target
通过开发新型蛋白质靶标的小分子抑制剂来治疗炎症性肠病
批准号：
449321
负责人：
Ogrodnik Natalia
金额：
$1.27万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-12-01 至 2021-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=449321&lang=en
关键词：
Biochemistry Chemical Biology Crystallography Drug Development Enzymatic Assays Immunology Inflammatory Bowel Disease Inhibitors Organic Chemistry Small Molecules

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Canada has one of the highest rates of inflammatory bowel disease (IBD) worldwide and this is expected to rise in the next decade. IBD is a burden on patients, healthcare and society. Despite recent advances in IBD therapies, many patients do not respond
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金